RXRX · Recursion Pharmaceuticals Inc. Class A Common Stock
View on chartInsiders & Stakes
| Lux Ventures IV, L.P. | ▼ Sell | Other | 13,021,519 Shares held | 12/7/2021 | View profile |
| Mubadala Investment Co PJSC 10% Owner | ▲ Buy | Open Market | 12,985,927 Shares held | 3/2/2023 | View profile |
| Blake Borgeson Director | ▼ Sell | Open Market | 6,158,287 Shares held | 9/1/2026 | View profile |
| Najat Khan CEO and President | ▼ Sell | Open Market | 2,072,890 Shares held | 9/8/2026 | View profile |
| Secora Michael Chief Financial Officer | ▼ Sell | Tax Withholding | 1,487,694 Shares held | 11/15/2024 | View profile |
| Dean Y. Li Director | ▲ Buy | Grant | 1,476,707 Shares held | 10/1/2026 | View profile |
| Ben R. Taylor Chief Financial Officer | ▼ Sell | Tax Withholding | 1,071,462 Shares held | 9/15/2026 | View profile |
| David Hallett Chief Scientific Officer | ▼ Sell | Tax Withholding | 1,043,837 Shares held | 8/17/2026 | View profile |
| Christopher Gibson Chief Executive Officer | ▼ Sell | Open Market | 883,735 Shares held | 6/5/2026 | View profile |
| Larson Tina Marriott President and COO | ▼ Sell | Tax Withholding | 506,852 Shares held | 11/15/2024 | View profile |
| Zavain Dar Director | ▲ Buy | Grant | 245,371 Shares held | 10/1/2026 | View profile |
| Mauro David J Chief Medical Officer | ▼ Sell | Tax Withholding | 225,429 Shares held | 11/15/2024 | View profile |
| Franziska Michor Director | ▲ Buy | Grant | 215,477 Shares held | 6/17/2026 | View profile |
| Robert Hershberg Director | ▲ Buy | Grant | 162,156 Shares held | 6/17/2026 | View profile |
| Virani Shafique Chief Corp. Dev. Officer | ▼ Sell | Open Market | 136,748 Shares held | 1/16/2024 | View profile |
| Elaine D. Sun Director | ▲ Buy | Grant | 135,981 Shares held | 6/17/2026 | View profile |
| Namandje Bumpus Director | ▼ Sell | Open Market | 127,632 Shares held | 6/18/2026 | View profile |
| Doyle Ramona Chief Medical Officer | ▼ Sell | Tax Withholding | 121,110 Shares held | 5/16/2022 | View profile |
| Burrell Terry-Ann Director | ▲ Buy | Grant | 71,254 Shares held | 7/1/2024 | View profile |
| R. Martin Chavez Director | ▲ Buy | Grant | 60,078 Shares held | 4/1/2024 | View profile |
| Bogue Zachary Director | ▲ Buy | Grant | 9,378 Shares held | 7/3/2023 | View profile |
Transaction History
| Zavain Dar | ▲ Buy | Grant | 4,607 | $0 | 10/1/2026 |
| Dean Y. Li | ▲ Buy | Grant | 3,378 | $0 | 10/1/2026 |
| Ben R. Taylor | ▼ Sell | Tax Withholding | 5,396 | $18K | 9/15/2026 |
| Najat Khan | ▼ Sell | Open Market | 22,408 | $79K | 9/8/2026 |
| Blake Borgeson | ▼ Sell | Open Market | 30,000 | $100K | 9/1/2026 |
| Najat Khan | ▼ Sell | Tax Withholding | 80,498 | $254K | 8/17/2026 |
| David Hallett | ▼ Sell | Tax Withholding | 26,657 | $84K | 8/17/2026 |
| Ben R. Taylor | ▼ Sell | Tax Withholding | 25,018 | $79K | 8/17/2026 |
| Blake Borgeson | ▼ Sell | Open Market | 30,000 | $98K | 8/4/2026 |
| Blake Borgeson | ▼ Sell | Open Market | 40,000 | $159K | 7/7/2026 |
| Zavain Dar | ▲ Buy | Grant | 5,109 | $0 | 7/1/2026 |
| Dean Y. Li | ▲ Buy | Grant | 3,747 | $0 | 7/1/2026 |
| Namandje Bumpus | ▼ Sell | Open Market | 3,963 | $13K | 6/18/2026 |
| Blake Borgeson | ▲ Buy | Grant | 88,424 | $0 | 6/17/2026 |
| Robert Hershberg | ▲ Buy | Grant | 88,424 | $0 | 6/17/2026 |
| Elaine D. Sun | ▲ Buy | Grant | 88,424 | $0 | 6/17/2026 |
| Franziska Michor | ▲ Buy | Grant | 88,424 | $0 | 6/17/2026 |
| Zavain Dar | ▲ Buy | Grant | 88,424 | $0 | 6/17/2026 |
| Dean Y. Li | ▲ Buy | Grant | 88,424 | $0 | 6/17/2026 |
| Namandje Bumpus | ▲ Buy | Grant | 88,424 | $0 | 6/17/2026 |
| Ben R. Taylor | ▼ Sell | Tax Withholding | 5,396 | $17K | 6/15/2026 |
| Christopher Gibson | ▼ Sell | Other | 40,000 | $0 | 6/5/2026 |
| Christopher Gibson | ▼ Sell | Open Market | 40,000 | $145K | 6/5/2026 |
| Najat Khan | ▼ Sell | Open Market | 23,588 | $84K | 6/5/2026 |
| Namandje Bumpus | ▼ Sell | Open Market | 4,386 | $16K | 6/3/2026 |
| Blake Borgeson | ▼ Sell | Open Market | 30,000 | $110K | 6/2/2026 |
| Christopher Gibson | ▼ Sell | Other | 40,000 | $0 | 5/22/2026 |
| Christopher Gibson | ▼ Sell | Open Market | 40,000 | $123K | 5/22/2026 |
| Christopher Gibson | ▼ Sell | Tax Withholding | 22,821 | $69K | 5/15/2026 |
| David Hallett | ▼ Sell | Tax Withholding | 26,657 | $81K | 5/15/2026 |
| Najat Khan | ▼ Sell | Tax Withholding | 62,701 | $191K | 5/15/2026 |
| Ben R. Taylor | ▼ Sell | Tax Withholding | 25,018 | $76K | 5/15/2026 |
| Christopher Gibson | ▼ Sell | Other | 60,000 | $0 | 5/7/2026 |
| Christopher Gibson | ▼ Sell | Open Market | 40,000 | $135K | 5/7/2026 |
| Christopher Gibson | ▼ Sell | Gift | 20,000 | $0 | 5/7/2026 |
| Blake Borgeson | ▼ Sell | Open Market | 30,000 | $106K | 5/5/2026 |
| Christopher Gibson | ▼ Sell | Other | 40,000 | $0 | 4/22/2026 |
| Christopher Gibson | ▼ Sell | Open Market | 40,000 | $144K | 4/22/2026 |
| Christopher Gibson | ▼ Sell | Other | 40,000 | $0 | 4/7/2026 |
| Christopher Gibson | ▼ Sell | Open Market | 40,000 | $124K | 4/7/2026 |
| Blake Borgeson | ▼ Sell | Open Market | 30,000 | $93K | 4/7/2026 |
| Ben R. Taylor | ▼ Sell | Tax Withholding | 48,028 | $149K | 4/6/2026 |
| Zavain Dar | ▲ Buy | Grant | 4,902 | $0 | 4/1/2026 |
| Dean Y. Li | ▲ Buy | Grant | 3,268 | $0 | 4/1/2026 |
| Christopher Gibson | ▼ Sell | Open Market | 40,000 | $130K | 3/23/2026 |
| Christopher Gibson | ▼ Sell | Other | 40,000 | $0 | 3/23/2026 |
| Ben R. Taylor | ▼ Sell | Open Market | 7,956 | $27K | 3/17/2026 |
| Ben R. Taylor | ▼ Sell | Tax Withholding | 7,075 | $24K | 3/16/2026 |
| Christopher Gibson | ▼ Sell | Other | 20,000 | $0 | 3/9/2026 |
| Christopher Gibson | ▼ Sell | Gift | 20,000 | $0 | 3/9/2026 |
| Najat Khan | ▼ Sell | Open Market | 28,298 | $95K | 3/9/2026 |
| Blake Borgeson | ▼ Sell | Open Market | 170,000 | $588K | 3/3/2026 |
| Christopher Gibson | ▼ Sell | Other | 40,000 | $0 | 2/19/2026 |
| Christopher Gibson | ▼ Sell | Open Market | 40,000 | $138K | 2/19/2026 |
| Ben R. Taylor | ▼ Sell | Open Market | 13,426 | $41K | 2/18/2026 |
| Ben R. Taylor | ▼ Sell | Tax Withholding | 11,908 | $42K | 2/17/2026 |
| Najat Khan | ▼ Sell | Tax Withholding | 14,280 | $50K | 2/17/2026 |
| Christopher Gibson | ▼ Sell | Tax Withholding | 27,265 | $95K | 2/17/2026 |
| David Hallett | ▼ Sell | Tax Withholding | 11,908 | $42K | 2/17/2026 |
| Najat Khan | ▲ Buy | Grant | 1,673,546 | $0 | 2/6/2026 |
| David Hallett | ▲ Buy | Grant | 502,064 | $0 | 2/6/2026 |
| David Hallett | ▲ Buy | Grant | 24,254 | $0 | 2/6/2026 |
| David Hallett | ▼ Sell | Tax Withholding | 11,400 | $45K | 2/6/2026 |
| Najat Khan | ▲ Buy | Grant | 30,346 | $0 | 2/6/2026 |
| Najat Khan | ▼ Sell | Tax Withholding | 10,364 | $41K | 2/6/2026 |
| Ben R. Taylor | ▲ Buy | Grant | 446,279 | $0 | 2/6/2026 |
| Ben R. Taylor | ▲ Buy | Grant | 24,254 | $0 | 2/6/2026 |
| Ben R. Taylor | ▼ Sell | Tax Withholding | 11,400 | $45K | 2/6/2026 |
| Christopher Gibson | ▲ Buy | Grant | 30,346 | $0 | 2/6/2026 |
| Christopher Gibson | ▼ Sell | Tax Withholding | 10,364 | $37K | 2/6/2026 |
| Christopher Gibson | ▼ Sell | Other | 40,000 | $0 | 2/4/2026 |
| Christopher Gibson | ▼ Sell | Open Market | 40,000 | $165K | 2/4/2026 |
| Blake Borgeson | ▼ Sell | Open Market | 220,000 | $924K | 2/3/2026 |
| Christopher Gibson | ▼ Sell | Other | 40,000 | $0 | 1/20/2026 |
| Christopher Gibson | ▼ Sell | Open Market | 40,000 | $179K | 1/20/2026 |
| Blake Borgeson | ▼ Sell | Open Market | 220,000 | $959K | 1/6/2026 |
| Christopher Gibson | ▼ Sell | Open Market | 40,000 | $170K | 1/5/2026 |
| Christopher Gibson | ▼ Sell | Other | 60,000 | $0 | 1/5/2026 |
| Christopher Gibson | ▼ Sell | Gift | 20,000 | $0 | 1/5/2026 |
| Zavain Dar | ▲ Buy | Grant | 3,571 | $0 | 1/2/2026 |
| Dean Y. Li | ▲ Buy | Grant | 2,381 | $0 | 1/2/2026 |
| Ben R. Taylor | ▼ Sell | Open Market | 21,383 | $89K | 12/29/2025 |
| Najat Khan | ▼ Sell | Open Market | 124,403 | $549K | 12/22/2025 |
| Christopher Gibson | ▼ Sell | Other | 40,000 | $0 | 12/19/2025 |
| Christopher Gibson | ▼ Sell | Open Market | 40,000 | $180K | 12/19/2025 |
| Ben R. Taylor | ▼ Sell | Tax Withholding | 7,057 | $31K | 12/15/2025 |
| Christopher Gibson | ▼ Sell | Other | 60,000 | $0 | 12/4/2025 |
| Christopher Gibson | ▼ Sell | Open Market | 40,000 | $185K | 12/4/2025 |
| Christopher Gibson | ▼ Sell | Gift | 20,000 | $0 | 12/4/2025 |
| Blake Borgeson | ▼ Sell | Open Market | 220,000 | $961K | 12/2/2025 |
| Ben R. Taylor | ▼ Sell | Tax Withholding | 2,271 | $9K | 11/25/2025 |
| Christopher Gibson | ▼ Sell | Other | 40,000 | $0 | 11/19/2025 |
| Christopher Gibson | ▼ Sell | Open Market | 40,000 | $166K | 11/19/2025 |
| Ben R. Taylor | ▼ Sell | Tax Withholding | 11,908 | $49K | 11/17/2025 |
| Najat Khan | ▼ Sell | Tax Withholding | 17,584 | $73K | 11/17/2025 |
| Christopher Gibson | ▼ Sell | Tax Withholding | 40,390 | $167K | 11/17/2025 |
| Najat Khan | ▲ Buy | Grant | 84,925 | $0 | 11/5/2025 |
| Christopher Gibson | ▼ Sell | Other | 60,000 | $0 | 11/4/2025 |
| Christopher Gibson | ▼ Sell | Open Market | 40,000 | $208K | 11/4/2025 |
| Christopher Gibson | ▼ Sell | Gift | 20,000 | $0 | 11/4/2025 |
| Christopher Gibson | ▼ Sell | Other | 100,000 | $0 | 10/23/2025 |
| Christopher Gibson | ▼ Sell | Open Market | 100,000 | $570K | 10/23/2025 |
| Christopher Gibson | ▼ Sell | Other | 120,000 | $0 | 10/10/2025 |
| Christopher Gibson | ▼ Sell | Open Market | 100,000 | $604K | 10/10/2025 |
| Christopher Gibson | ▼ Sell | Gift | 20,000 | $0 | 10/10/2025 |
| Dean Y. Li | ▲ Buy | Grant | 1,961 | $0 | 10/1/2025 |
| Zavain Dar | ▲ Buy | Grant | 2,941 | $0 | 10/1/2025 |
| Christopher Gibson | ▼ Sell | Other | 100,000 | $0 | 9/25/2025 |
| Christopher Gibson | ▼ Sell | Open Market | 100,000 | $476K | 9/25/2025 |
| Ben R. Taylor | ▼ Sell | Tax Withholding | 7,057 | $34K | 9/15/2025 |
| Christopher Gibson | ▼ Sell | Other | 120,000 | $0 | 9/10/2025 |
| Christopher Gibson | ▼ Sell | Open Market | 100,000 | $471K | 9/10/2025 |
| Christopher Gibson | ▼ Sell | Gift | 20,000 | $0 | 9/10/2025 |
| Christopher Gibson | ▼ Sell | Other | 100,000 | $0 | 8/26/2025 |
| Christopher Gibson | ▼ Sell | Open Market | 100,000 | $484K | 8/26/2025 |
| Najat Khan | ▼ Sell | Open Market | 36,599 | $202K | 8/18/2025 |
| Ben R. Taylor | ▼ Sell | Tax Withholding | 11,908 | $67K | 8/15/2025 |
| Christopher Gibson | ▼ Sell | Tax Withholding | 40,390 | $228K | 8/15/2025 |
| Najat Khan | ▼ Sell | Tax Withholding | 3,789 | $21K | 8/15/2025 |
| Christopher Gibson | ▼ Sell | Other | 423,666 | $0 | 8/11/2025 |
| Christopher Gibson | ▼ Sell | Open Market | 500,300 | $2.6M | 8/11/2025 |
| Christopher Gibson | ▼ Sell | Gift | 10,000 | $0 | 8/11/2025 |
| Christopher Gibson | ▼ Sell | Other | 100,000 | $0 | 8/11/2025 |
| Christopher Gibson | ▼ Sell | Open Market | 100,000 | $528K | 8/11/2025 |
| Christopher Gibson | ▼ Sell | Other | 17,875 | $0 | 8/11/2025 |
| Christopher Gibson | ▼ Sell | Open Market | 17,875 | $94K | 8/11/2025 |
| Dean Y. Li | ▲ Buy | Grant | 1,949 | $0 | 7/1/2025 |
| Zavain Dar | ▲ Buy | Grant | 2,924 | $0 | 7/1/2025 |
| Dean Y. Li | ▲ Buy | Grant | 22,016 | $0 | 6/18/2025 |
| Blake Borgeson | ▲ Buy | Grant | 22,016 | $0 | 6/18/2025 |
| Franziska Michor | ▲ Buy | Grant | 22,016 | $0 | 6/18/2025 |
| Robert Hershberg | ▲ Buy | Grant | 22,016 | $0 | 6/18/2025 |
| Zavain Dar | ▲ Buy | Grant | 22,016 | $0 | 6/18/2025 |
| Namandje Bumpus | ▲ Buy | Grant | 11,008 | $0 | 6/18/2025 |
| Elaine D. Sun | ▲ Buy | Grant | 11,008 | $0 | 6/18/2025 |
| Ben R. Taylor | ▼ Sell | Tax Withholding | 7,057 | $35K | 6/16/2025 |
| Najat Khan | ▼ Sell | Tax Withholding | 3,796 | $16K | 5/15/2025 |
| Ben R. Taylor | ▼ Sell | Tax Withholding | 11,908 | $51K | 5/15/2025 |
| Christopher Gibson | ▼ Sell | Tax Withholding | 36,197 | $154K | 5/15/2025 |
| Zavain Dar | ▲ Buy | Grant | 2,745 | $0 | 4/1/2025 |
| Ben R. Taylor | ▼ Sell | Tax Withholding | 26,571 | $135K | 4/1/2025 |
| Dean Y. Li | ▲ Buy | Grant | 2,268 | $0 | 4/1/2025 |
| Christopher Gibson | ▼ Sell | Open Market | 138,574 | $837K | 3/27/2025 |
| Ben R. Taylor | ▼ Sell | Tax Withholding | 7,057 | $48K | 3/17/2025 |
| Namandje Bumpus | ▲ Buy | Grant | 36,549 | $0 | 3/17/2025 |
| Elaine D. Sun | ▲ Buy | Grant | 36,549 | $0 | 3/17/2025 |
| Christopher Gibson | ▼ Sell | Other | 20,000 | $0 | 3/6/2025 |
| Christopher Gibson | ▼ Sell | Open Market | 20,000 | $127K | 3/6/2025 |
| Christopher Gibson | ▼ Sell | Other | 20,000 | $0 | 3/5/2025 |
| Christopher Gibson | ▼ Sell | Open Market | 20,000 | $132K | 3/5/2025 |
| Christopher Gibson | ▼ Sell | Tax Withholding | 17,132 | $182K | 2/18/2025 |
| Ben R. Taylor | ▼ Sell | Tax Withholding | 10,879 | $116K | 2/18/2025 |
| Christopher Gibson | ▼ Sell | Other | 20,000 | $0 | 2/6/2025 |
| Christopher Gibson | ▼ Sell | Open Market | 20,000 | $162K | 2/6/2025 |
| Christopher Gibson | ▼ Sell | Other | 20,000 | $0 | 2/5/2025 |
| Christopher Gibson | ▼ Sell | Open Market | 20,000 | $154K | 2/5/2025 |
| Ben R. Taylor | ▲ Buy | Grant | 35,018 | $0 | 2/3/2025 |
| Ben R. Taylor | ▲ Buy | Grant | 13,922 | $0 | 2/3/2025 |
| Ben R. Taylor | ▼ Sell | Tax Withholding | 6,544 | $47K | 2/3/2025 |
| Najat Khan | ▲ Buy | Grant | 210,113 | $0 | 2/3/2025 |
| Najat Khan | ▲ Buy | Grant | 8,049 | $0 | 2/3/2025 |
| Najat Khan | ▼ Sell | Tax Withholding | 2,753 | $20K | 2/3/2025 |
| Christopher Gibson | ▲ Buy | Grant | 525,283 | $0 | 2/3/2025 |
| Christopher Gibson | ▲ Buy | Grant | 16,809 | $0 | 2/3/2025 |
| Christopher Gibson | ▼ Sell | Tax Withholding | 5,569 | $40K | 2/3/2025 |
| Christopher Gibson | ▼ Sell | Open Market | 20,000 | $141K | 1/10/2025 |
| Christopher Gibson | ▼ Sell | Other | 20,000 | $0 | 1/10/2025 |
| Christopher Gibson | ▼ Sell | Other | 20,000 | $0 | 1/8/2025 |
| Christopher Gibson | ▼ Sell | Open Market | 20,000 | $146K | 1/8/2025 |
| Zavain Dar | ▲ Buy | Grant | 1,907 | $0 | 1/2/2025 |
| Dean Y. Li | ▲ Buy | Grant | 1,647 | $0 | 1/2/2025 |
| Blake Borgeson | ▲ Buy | Grant | 1,734 | $0 | 1/2/2025 |
| Ben R. Taylor | ▲ Buy | Grant | 370,343 | $0 | 12/19/2024 |
| Ben R. Taylor | ▼ Sell | Tax Withholding | 7,057 | $49K | 12/17/2024 |
| Ben R. Taylor | ▼ Sell | Tax Withholding | 15,668 | $95K | 12/16/2024 |
| Christopher Gibson | ▼ Sell | Other | 20,000 | $0 | 12/5/2024 |
| Christopher Gibson | ▼ Sell | Open Market | 20,000 | $142K | 12/5/2024 |
| Christopher Gibson | ▼ Sell | Other | 20,000 | $0 | 12/4/2024 |
| Christopher Gibson | ▼ Sell | Open Market | 20,000 | $143K | 12/4/2024 |
| Franziska Michor | ▲ Buy | Grant | 30,618 | — | 11/20/2024 |
| Franziska Michor | ▲ Buy | Grant | 15,335 | $0 | 11/20/2024 |
| Franziska Michor | ▲ Buy | Grant | 17,694 | $0 | 11/20/2024 |
| Franziska Michor | ▲ Buy | Grant | 41,390 | $0 | 11/20/2024 |
| Larson Tina Marriott | ▼ Sell | Tax Withholding | 14,286 | $88K | 11/15/2024 |
| Christopher Gibson | ▼ Sell | Tax Withholding | 26,023 | $161K | 11/15/2024 |
| Secora Michael | ▼ Sell | Tax Withholding | 11,937 | $74K | 11/15/2024 |
| Mauro David J | ▼ Sell | Tax Withholding | 4,187 | $26K | 11/15/2024 |
| Christopher Gibson | ▼ Sell | Open Market | 20,000 | $147K | 11/14/2024 |
| Christopher Gibson | ▼ Sell | Other | 20,000 | $0 | 11/14/2024 |
| Secora Michael | ▲ Buy | Option Exercise | 39,375 | $87K | 11/13/2024 |
| Secora Michael | ▼ Sell | Open Market | 15,000 | $115K | 11/13/2024 |
| Christopher Gibson | ▼ Sell | Other | 20,000 | $0 | 11/13/2024 |
| Christopher Gibson | ▼ Sell | Open Market | 20,000 | $155K | 11/13/2024 |
| Secora Michael | ▼ Sell | Open Market | 15,000 | $115K | 11/12/2024 |
| Secora Michael | ▲ Buy | Option Exercise | 39,375 | $87K | 11/12/2024 |
| Blake Borgeson | ▼ Sell | Open Market | 11,447 | $87K | 11/12/2024 |
| Blake Borgeson | ▼ Sell | Open Market | 11,447 | $77K | 10/29/2024 |
| Larson Tina Marriott | ▼ Sell | Open Market | 6,000 | $38K | 10/24/2024 |
| Larson Tina Marriott | ▲ Buy | Option Exercise | 6,000 | $6K | 10/24/2024 |
| Blake Borgeson | ▼ Sell | Open Market | 11,447 | $76K | 10/15/2024 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Recursion Pharmaceuticals Stock Falls as Cathie Wood Adjusts Biotech Holdings
Recursion Pharmaceuticals shares have declined recently while the broader market improved. This movement coincides with Cathie Wood's recent portfolio adjustments, where she increased positions in several biotech stocks while reducing others. The stock is currently trading near the middle of its 52-week range, with analysts maintaining an average target price of $7.22.
Recursion Pharmaceuticals Stock Falls as Cathie Wood Adjusts Biotech Holdings. Recursion Pharmaceuticals shares have declined recently while the broader market improved. This movement coincides with Cathie Wood's recent portfolio adjustments, where she increased positions in several biotech stocks while reducing others. The stock is currently trading near the middle of its 52-week range, with analysts maintaining an average target price of $7.22.